Growth factors in bladder cancer

scientific article published on January 1995

Growth factors in bladder cancer is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1036182255
P356DOI10.1007/BF00191216
P698PubMed publication ID9116754

P2093author name stringM Liebert
P2860cites workSubnormal concentrations of urinary epidermal growth factor in patients with kidney diseaseQ68797034
Differential effects of epidermal growth factor (EGF) on cell locomotion and cell proliferation in a cloned human embryonal carcinoma-derived cell line in vitroQ68829391
Immunohistochemical localization of the epidermal growth factor receptor in normal human tissuesQ68912114
Tumor necrosis factor increases the number of epidermal growth factor receptors on human fibroblastsQ68936080
The TGF-alpha precursor expressed on the cell surface binds to the EGF receptor on adjacent cells, leading to signal transductionQ69052663
Epidermal growth factor receptor in human bladder cancer: a comparison of immunohistochemistry and ligand bindingQ69735943
Characterization and quantitation of the epidermal growth factor receptor in invasive and superficial bladder tumorsQ69746810
Imaging of human tumor xenografts with an indium-111-labeled anti-epidermal growth factor receptor monoclonal antibodyQ69755368
Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumoursQ69856767
Epidermal growth factor promotes the chemotactic migration of cultured rat intestinal epithelial cellsQ69873417
Transferrin receptor expression and the control of cell growthQ70160606
Flow cytometry in comparison with mitotic index in predicting disease outcome in transitional-cell bladder cancerQ70519925
Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patientsQ70537350
An essential heparin-binding domain in the fibroblast growth factor receptor kinaseQ70619107
A recombinant form of Pseudomonas exotoxin A containing transforming growth factor alpha near its carboxyl terminus for the treatment of bladder cancerQ70736838
Insulin-like growth factor binding protein 1 expression inhibits insulin-like growth factor I action in MCF-7 breast cancer cellsQ71613317
Interrelationship between expression of p53, proliferating cell nuclear antigen and c-erbB-2 in bladder cancerQ72236542
Insulin-like growth factorsQ72544380
Proliferative state of the urothelium with benign and atypical changes. Correlation with transferrin and epidermal growth factor receptors and blood group antigensQ72577693
Evidence for the potentiation of epidermal growth factor receptor tyrosine kinase activity by association with the detergent-insoluble cellular cytoskeleton: analysis of intact and carboxy-terminally truncated receptorsQ72614941
Urine from patients with transitional-cell carcinoma stimulates migration of capillary endothelial cellsQ72645182
Expression of c-erbB-2 protein in normal and neoplastic urothelium: lack of adverse prognostic effect in human urinary bladder cancerQ72689176
Pharmaceutical research in molecular oncologyQ72790769
Alterations in phenotypic biochemical markers in bladder epithelium during tumorigenesisQ23922988
Control of fibroblast growth factor receptor kinase signal transduction by heterodimerization of combinatorial splice variantsQ24308772
The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signalingQ24337017
Signal transduction by receptors with tyrosine kinase activityQ27860624
Receptors for the TGF-β familyQ28210923
The transforming growth factor-beta familyQ29615948
Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cellsQ29616544
Growth factor signaling by receptor tyrosine kinasesQ29618315
Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomasQ33881165
Receptors for epidermal growth factor and other polypeptide mitogensQ34163558
Signalling by receptor tyrosine kinasesQ34306539
The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organismsQ34349039
Peptide growth factors and inflammation, tissue repair, and cancerQ34531790
Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transductionQ35229509
Epidermal growth factor receptor and bladder cancer: a reviewQ35268041
Receptor tyrosine kinase substrates: src homology domains and signal transductionQ35344982
Reduced expression of TGF beta is associated with advanced disease in transitional cell carcinomaQ35976124
Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosisQ35979121
Epidermal growth factor--interactions with normal and malignant urothelium: in vivo and in situ studiesQ42521138
Significance of erbB-2 gene product as a target molecule for cancer therapyQ42799398
Increased levels of fibroblast growth factor-like activity in urine from patients with bladder or kidney cancerQ42804162
Epidermal growth factor and transforming growth factor-alpha induce differential processing of the epidermal growth factor receptorQ42833585
Epidermal growth factor-induced truncation of the epidermal growth factor receptorQ42835084
Recycling of epidermal growth factor-receptor complexes in A431 cells: identification of dual pathwaysQ43107632
Differential expression of a Mr approximately 90,000 cell surface transferrin receptor-related glycoprotein on murine B16 metastatic melanoma sublines selected for enhanced brain or ovary colonization.Q44268717
Evaluation of epidermal growth factor receptor DNA amplification and mRNA expression in bladder cancerQ45274822
Intravesical administration of radiolabeled antitumor monoclonal antibody in bladder carcinomaQ45286409
Transmembrane TGF-alpha precursors activate EGF/TGF-alpha receptors.Q45931354
Epidermal-growth-factor-receptor expression is associated with rapid tumor proliferation in bladder cancerQ46320350
The human transferrin receptor gene: genomic organization, and the complete primary structure of the receptor deduced from a cDNA sequenceQ48385617
Effect of epidermal growth factor on membrane motility and cell locomotion in cultures of human clonal glioma cellsQ53437421
Amplification and expression of the c-erb B-2/neu proto-oncogene in human bladder cancer.Q53511518
The epidermal growth factor receptor and the prognosis of bladder cancer.Q53797133
In vitro Sensitivity Testing of Human Bladder Cancers and Cell Lines to TP-40, a Hybrid Protein with selective Targeting and CytotoxicityQ62267749
Increased immunodetection of acidic fibroblast growth factor in bladder cancer, detectable in urineQ63966550
An immunohistologic evaluation of C-erbB-2 gene product in patients with urinary bladder carcinomaQ67522705
aFGF Content Increases with Malignancy in Human Chondrosarcoma and Bladder CancerQ67709845
The role of microfilaments in the capping of epidermal growth factor receptor in A431 cellsQ67986179
Upregulation of epidermal growth factor receptor induced by alpha-interferon in human epidermoid cancer cellsQ68201732
Transferrin receptor expression by human bladder transitional cell carcinomasQ68223047
Transforming growth factor beta 1 inhibits epidermal growth factor receptor endocytosis and down-regulation in cultured fetal rat hepatocytesQ68244964
Interaction of basic fibroblast growth factor with extracellular matrix and receptorsQ68273440
Lymphoscintigraphy with 13I-labelled epidermal growth factorQ68291982
Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumorsQ68748541
Transferrin receptor expression in primary superficial human bladder tumours identifies patients who develop recurrencesQ68786449
Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladderQ35984818
Increased epidermal growth factor receptor gene expression by gamma-interferon in a human breast carcinoma cell lineQ35992885
125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblastsQ36198091
Calcium signals in growth factor signal transduction.Q36205896
Down regulation of epidermal growth factor receptors: direct demonstration of receptor degradation in human fibroblastsQ36210313
Cell movement elicited by epidermal growth factor receptor requires kinase and autophosphorylation but is separable from mitogenesisQ36233701
Receptor tyrosine kinase signaling required for integrin alpha v beta 5-directed cell motility but not adhesion on vitronectinQ36234780
Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movementQ36234800
Signal transduction via the MAP kinases: proceed at your own RSK.Q36381460
Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptorsQ36405679
A dual receptor system is required for basic fibroblast growth factor activityQ36428185
Sequestration and release of basic fibroblast growth factorQ36463376
Regulators and Effectors of ras ProteinsQ36467146
Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neckQ36467548
Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c-erbB) in human brain tumorsQ36787477
Biological Activities of Fibroblast Growth FactorsQ36940855
Structure, function and transforming potential of the epidermal growth factor receptorQ37936898
Transforming growth factor-alpha. A model for membrane-anchored growth factors.Q38006301
Autocrine regulation of cell growth and transformation by basic fibroblast growth factorQ38037837
Phenotypic and cytogenetic characterization of human bladder urothelia expanded in vitro.Q38575583
Transforming growth factor alphaQ39517957
Transforming growth factor-alpha: structure and biological activitiesQ39754902
Angiogenesis and colonization in the tumor metastatic process: basic and applied advancesQ40388392
Role of Insulin‐like Growth Factor Binding Proteins in Modifying IGF ActionsaQ40491193
Epidermal growth factor-related peptides in the pathogenesis of human breast cancer.Q40623950
The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapiesQ40624402
Targeted toxins as anticancer agentsQ40624536
Gene therapy through signal transduction pathways and angiogenic growth factors as therapeutic targets in breast cancer.Q40676742
The ins and outs of fibroblast growth factorsQ40694270
Epidermal Growth Factor (Urogastrone) in Human Fluids: Size Heterogeneity*Q40706441
Oncogene regulation by growth factorsQ40728904
Homologous Radioimmunoassay for Human Epidermal Growth Factor (Urogastrone)*Q40740683
How receptor tyrosine kinases activate Ras.Q40778358
Transforming growth factor beta and the cell surface in tumor progressionQ40801234
EGF receptor in neoplasia and metastasisQ40801239
Membrane-anchored growth factors.Q40856819
Phylogeny of the insulin-like growth factors (IGFs) and receptors: a molecular approachQ40858628
Molecular dynamics of insulin/IGF-I receptor transmembrane signalingQ40858632
Growth factors: regulation of normal and neoplastic growthQ40882275
Evaluation of epidermal growth factor receptors in bladder tumoursQ41153245
Expression of basic fibroblast growth factor and its receptor in an invasive bladder carcinoma cell lineQ41556505
Characterization of insulin-like growth factor I binding sites in human bladder cancer cell linesQ41580263
Immunohistochemical detection of acidic fibroblast growth factor in bladder transitional cell carcinomaQ41648912
Ha-ras induction of the invasive phenotype results in up-regulation of epidermal growth factor receptors and altered responsiveness to epidermal growth factor in human papillary transitional cell carcinoma cellsQ41669431
The expression of epidermal growth factor receptor on human bladder cancer: potential use in radioimmunoscintigraphyQ41675811
Tumor necrosis factor modulates epidermal growth factor receptor phosphorylation and kinase activity in human tumor cells. Correlation with cytotoxicity.Q41758565
Expression of c-erbB-2 gene product in urinary bladder cancerQ41898078
Analysis of mammalian fibroblast transformation by normal and mutated human EGF receptorsQ42054821
Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladderQ42382564
Transforming growth factor-beta controls receptor levels for epidermal growth factor in NRK fibroblastsQ42453725
Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinomaQ42465267
Transferrin receptor activity as a marker in transitional cell carcinoma of the bladderQ42475744
P433issue6
P304page(s)349-355
P577publication date1995-01-01
P1433published inWorld Journal of UrologyQ15750774
P1476titleGrowth factors in bladder cancer
P478volume13

Reverse relations

cites work (P2860)
Q50753439Binding, internalization and degradation of EGF-dextran conjugates in two human bladder-cancer cell lines.
Q77918607Conjugate chemistry and cellular processing of EGF-dextran
Q73524505High yield direct 76Br-bromination of monoclonal antibodies using chloramine-T

Search more.